%PDF-1.4
%
347 0 obj
<>
endobj
346 0 obj
<[1 0 R/XYZ 0 792 0]>>
endobj
373 0 obj
<>stream
2021-03-22T19:21:25Z
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/89.0.4389.82 Safari/537.36
2024-03-29T04:17:44-07:00
2024-03-29T04:17:44-07:00
Skia/PDF m89
application/pdf
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era
uuid:f4804606-1dd1-11b2-0a00-9e0827bd7200
uuid:f480460b-1dd1-11b2-0a00-880000000000
endstream
endobj
344 0 obj
<>
endobj
2 0 obj
<>
endobj
68 0 obj
<>
endobj
118 0 obj
<>
endobj
343 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/StructParents 24/Type/Page>>
endobj
374 0 obj
[378 0 R 379 0 R]
endobj
375 0 obj
<>stream
Hmo
/";rB$GE4@ZEQb+dI9ۗ{} "Ð槕I_.`*~B))zw+% M54V@mWG,-<xC/[R&3Fi]4aӌ `;B˺cͧMN/ڈeZX[\D/\AR㸏XOTd3SctFȨVi!
qݵ
gl惕LxQQ[ڈ#PJG}WTT6@V2W5DZ'C"5m:%/0Os
Pƛf¿.j5課.*.1ݦY)ݲYuTT*:e|v^,oY5//o53%aqfxk3vi@#~] Z|K\?!1Jg9<4IN w 1<}
7(_kD&:Ȩ:9cpU6>=UcQgU7;PۏMPVbۏe/L)jM_n6I7 DtsN
c݀>MKK«չ&ZcztԕV3VCq?_|Ijc!d;[Rd =d,'lI
RVg=@ι8ÃOi_t:qD@ERN`MMGrwkd,\AUhR:aDCm"@Ɵv|+Lzj:9RőPˠ>+XB6s -cg+Q FDDf+m"JFͯF5Sz5G.#,[[u`dP*:Xù:PZL8Iͬ'56Wws5HT"eHel @
>1)~K0~;pm )JFpϺ6NM[fk''?X3{
'c\If}M-%A#&=䬩>Goδ>mn"(]M3?8O8,4<[FhcdcZ nx=Rsv){#(G5R JdECf8%g Y5>E$'GO`LkrD2Y_A42Z2QPwI9~9dpep#HHv1aa=?DgȸHWK:e0]{*^'ET!^T{wl$<&}D~U|} 6'L|tU[o^N!c#@MbC__XRlHXG-j\!.5/vXFJпFZ%7^צkx;ށ
%߲Y+:֥, @wy&Њie2
VNt[|6HOڂm/rAlz
[